Bullish on Bristol Myers Squibb
Update 9/27/2024: Cobenfy (formerly KarXT) was Approved by the FDA. 1st Schizophrenia drug in a long time, and the 1st that doesn’t block Dopamine. Which is a common reason people … Read More
Update 9/27/2024: Cobenfy (formerly KarXT) was Approved by the FDA. 1st Schizophrenia drug in a long time, and the 1st that doesn’t block Dopamine. Which is a common reason people … Read More
Nvidia’s fall from grace has been nothing short of epic, with a loss of 20+ points since earnings. Then dropping almost 10% today amongst a sea of red. There is … Read More
Massive Sell Off So why the massive sell off? Have people just gotten tired of intel’s slow movement and constant retractions? Not exactly, while that could be annoying for anything … Read More
Bringing Connectivity to the Globe AST SpaceMobile is a groundbreaking company aiming to revolutionize global communication by creating the world’s first and only space-based cellular broadband network. This innovative system … Read More
GSK’s Jemperli: Awaitng FDA Decision on Expanding Treatment Options. GlaxoSmithKline (GSK)’s immunotherapy drug, Jemperli, is currently under review by the FDA for potential approval in additional cancer indications. The drug … Read More
Cold Storage Giant’s IPO Lineage Logistics, a behemoth in the cold storage and logistics sector, is set to make a significant entrance into the public market through its Initial Public … Read More
CrowdStrike Update Fallout Continues: Microsoft Mitigates, Delta Struggles The ripple effects of the CrowdStrike software update incident are still being felt, with Microsoft making significant progress in resolving issues while … Read More
Buffett Sells $1.5 Billion of BAC A Vote of Confidence In 2011, when Bank of America was still grappling with the aftermath of the 2008 financial crisis, Warren Buffett made … Read More
Don’t Let Emotions Cloud Your Judgment: Understanding FOMO and FUD in Crypto The world of cryptocurrency is exciting, but it can also be a rollercoaster of emotions. Two emotions that … Read More
Nvidia’s Stock Soars: Riding the AI Boom to the Moon Nvidia’s stock has been on a tear in 2024, skyrocketing over 150% in the first half of the year. This … Read More